# Innate Pharma SA: Form 6-K, filed Nov 5, 2025

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2025-11-05
- Accepted by EDGAR: Nov 5, 2025, 06:06 ET
- Period: 2025-11-05
- Accession: 0001628280-25-049202
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000162828025049202/a6ktemplate-iphnovember5.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000162828025049202/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000162828025049202/a6ktemplate-iphnovember5.htm

Filed Nov 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-049202. Last ingested by Listed: Oct 27, 2026, 07:14 ET. No prices; not investment advice.